Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis

Thorax

Volumn 57, Issue 10, 2002, Pages 897-901

  Stridh, Helene ^a   Planck, A ^a   Gigliotti, D ^b   Eklund, A ^a   Grunewald, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS ANTIBODY; LIPOCORTIN 5; T LYMPHOCYTE RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GRANULOMA; HUMAN; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; MALE; MORPHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SARCOIDOSIS; SIGNAL DETECTION; STIMULUS RESPONSE; T LYMPHOCYTE;

ADULT; ANNEXIN A5; APOPTOSIS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CASPASES; CELLS, CULTURED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; SARCOIDOSIS, PULMONARY; T-LYMPHOCYTES;

EID: 0036795831     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.10.897     Document Type: Article

References (33)

1. Newman L, Rose C, Maier L. Medical progress: sarcoidosis. N Engl J Med 1997;336:1224-33.
2. Müller-Quernheim J. Sarcoidosis: immunopathogenic concepts and their clinical application. Eur Respir J 1998;12:716-38.
3. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-34.
4. Pabst R, Tschering T. Lymphocyte dynamic: caution in interpreting BAL numbers. Thorax 1997;52:1078-80.
5. Agostini C, Zambello R, Sancetta R, et al. Expression of tumor necrosing factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996;153:1359-67.
6. Ziegenhagen MW, Benner UK, Zissel G, et al. Sarcoidosis: TNF-α release from alveolar macrophages and serum levels of sIL-2R are prognostic markers. Am J Respir Crit Care Med 1997;156:1586-92.
7. Tagaya Y, Bamford RN, DeFilippis AP, et al. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathway who's expression is controlled at multiple levels. Immunity 1996;4:329-36.
8. Bulfone-Paus S, Ungureanu D, Pohl T, et al. Interleukin-15 protects from lethal apoptosis in vivo. Nature Med 1997;3:1124-8.
9. Agostini C, Trentin L, Facco M, et al. Role of IL-15, IL-2 and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996;157:910-8.
10. Jullien D, Sieling PA, Uyemara K, et al. IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 1997;158:800-6.
11. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-22.
12. Wilhelm S, Wagner H, Häcker G. Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur J Immunol 1998;28:891-900.
13. Alam A, Cohen LY, Aouad S, et al. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in non-apoptotic cells. J Exp Med 1999;12:1879-90.
14. Kennedy NJ, Kataoka T, Tschopp J, et al. Caspase activation is required for T cell proliferation. J Exp Med 1999;190:1891-6.
15. Los M, Stroh C, Jänike RU, et al. Caspases: more than just killers? Trends Immunol 2001;22:31-4.
16. Stridh H, Cotgreave I, Müller M, et al. Organotin-induced caspase activation and apoptosis in human peripheral blood lymphocytes. Chem Res Toxicol 2001;14:791-8.
17. Neurath MF, Finotto S, Fuss I, et al. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the question. Trends Immunol 2001;22:21-5.
18. Agostini C, Perin A, Semenzato G. Cell apoptosis and granulomatous lung disease. Curr Opin Pulm Med 1998;4:261-6.
19. Agostini C, Adami F, Semenzato G. New insights into the sarcoid granuloma. Curr Opin Rheumatol 2000;12:71-6.
20. Cree IA, Nurbhai S, Milne G, et al. Cell death in granulomata: the role of apoptosis. J Clin Pathol 1987;40:1314-9.
21. Agostini C, Zambello R, Sancetta R, et al. Expression of tumor necrosing factor-receptor superfamily members by lung T-lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996;153:1359-67.
22. Kunitake R, Kuwano H, Miyazaki N, et al. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur Respir J 1999;13:1329-37.
23. Dai H, Guzman J, Costabel U. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis. Eur Respir J 1999;13:1451-4.
24. Kaan PM, Hegele RG, Hayashi S, et al. Expression of bcl-2 and Epstein-Barr virus LMP-1 in lymphocytic interstitial pneumonia. Thorax 1997;52:12-6.
25. Stridh H, Gigliotti D, Orrenius S, et al. The role of calcium in pre- and postmitochondrial events in tributyltin-induced T-cell apoptosis. Biochem Biophys Res Comm 1999;266:460-5.
26. Stridh H, Fava E, Single B, et al. Tributyltin-induced apoptosis requires glycolytic ATP production. Chem Res Toxicol 1999;12:874-82.
27. Stridh H, Orrenius S, Hampton MB. Caspase involvement in the induction of apoptosis by the environmental toxicants tributyltin and triphenyltin. Toxicol Appl Pharmacol 1999;156:141-6.
28. Stridh H, Kimland M, Jones DP, et al. Cytochrome c release and caspase activation in hydrogen peroxide and tributyltin-induced apoptosis. FEBS Lett 1998;429:351-5.
29. American Thoracic Society. Statement of sarcoidosis. Am J Respir Crit Care Med 1999;160:736-55.
30. Anon. Meeting report: Third WASOG meeting. Consensus conference: activity of sarcoidosis. Eur Respir J 1994;7:624-7.
31. Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin-converting enzym activity in serum in sarcoidosis. Thorax 1986;41:629-34.
32. Katchar K, Wahlström J, Eklund A, et al. Highly activated T cell receptor AV2S3+CD4+ lung T cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 2001;163:1540-5.
33. Wahlström JM, Berlin M, Sköld CM, et al. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999;54:339-46.